Enrolling by invitationPhase 1NCT05301361

Sensitivity of the NIH Toolbox to Stimulant Treatment in Intellectual Disabilities

Studying Fragile X syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of California, Davis
Intervention
Methylphenidate Oral Solution(drug)
Enrollment
68 enrolled
Eligibility
6-24 years · All sexes
Timeline
2023 – 2026

Study locations (3)

Collaborators

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05301361 on ClinicalTrials.gov

Other trials for Fragile X syndrome

Additional recruiting or active studies for the same condition.

See all trials for Fragile X syndrome →

← Back to all trials